NO ATC C07AG01 · updated 2 Nov 2026
Labetalol shortage in Norway
Is there a Labetalol shortage in Norway?
Yes. As of 2 Nov 2026, 1 Labetalol product is reported short in Norway, the first since 15 Jul 2022. The company estimate for the return is 30 Jan 2028. Main reason: commercial decision or withdrawal.
Also short in Canada. All countries.
Affected products in Norway
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| NO | Trandate 5 mg/ml injeksjonsvæske, oppløsning, 5x20 ml ampulle | Aspen Pharma Trading Limited | 15 Jul 2022 | 30 Jan 2028 | Commercial decision or withdrawal Lavt salg |
Source
DMP (Norwegian Medical Products Agency). Official list. Ongoing and announced shortages reported by companies; one row per pack (varenummer).